Nomsa Tsikai

Advancing Health Equity in Global Oncology: A Collaborative Academic-Cancer Society-Industry Program to Address Health Disparities in Sub-Saharan Africa

Kenneth Wing Merrell, Ben Kamdem-Talom, Hannah Ayettey Anie, Christine Wekesa et autres

PURPOSE: Cancer care capacity in sub-Saharan Africa (SSA) is constrained by late diagnosis and limited treatment access. Few funding mechanisms support innovative, locally led programs to address these challenges. A collaborative initiative was developed to strengthen oncology care through quality improvement (QI) …

us, Ghana, Kenya, Zimbabwe, Afrique du Sud, Nigéria, Cameroun, ca (code pays fourni par la source)

Association between human papillomavirus and behaviour, clinicopathology, and cervical cancer outcome in Zimbabwean women: a cross-sectional study

Oppah Kuguyo, Alice Matimba, Nomsa Tsikai, Mugove Gerald Madziyire et autres

BACKGROUND: Less than 10% of women infected with distinct human papillomavirus (HPV) develop cervical cancer, suggesting the need for secondary driving factors for carcinogenesis. This study describes factors associated with distinct HPV infections using cervical cancer cohort as a model. Moreover, we …

Afrique du Sud, Zimbabwe (code pays fourni par la source)

EVALUATION OF SEVERE RADIATION INDUCED SKIN TOXICITY (RIST) IN BLACK WOMEN RECEIVING ADJUVANT RADIOTHERAPY FOR BREAST CANCER IN ZIMBABWE. A PROSPECTIVE COHORT STUDY

Melinda Mushonga, Shirley Chibonda, Anna Mary Nyakabau, Danielle Lee Rodin et autres

PATIENT- AND PHYSICIAN-REPORTED SYMPTOM PROFILE FOR SEVERE RADIATION-INDUCED DERMATITIS IN BLACK WOMEN WITH FITZPATRICK SKIN TYPE IV-VI UNDERGOING ADJUVANT RADIOTHERAPY FOR BREAST CANCER

Melinda Mushonga, Shirley Chibonda, Ntokozo Ndlovu, Tinashe Mazhindu et autres

Prevalence and predictors for cisplatin-induced toxicities in Zimbabwean women with cervical cancer

Oppah Kuguyo, Alice Matimba, Mugove Gerald Madziyire, Thulani Leslie Magwali et autres

Aim: To describe treatment-induced toxicities (TITs) and associated factors in Zimbabwean cancer patients receiving cisplatin. Methods: In total, 252 Zimbabwean women with cervical cancer, receiving cisplatin were followed up over 12 months for TITs and disease status. Results: Peripheral neuropathy (70%) and …

Zimbabwe, Afrique du Sud (code pays fourni par la source)

A cervical cancer biorepository for pharmacogenomics research in Zimbabwe

Oppah Kuguyo, Nyasha Chambwe, Charles F. B. Nhachi, Nomsa Tsikai et autres

BACKGROUND: Research infrastructures such as biorepositories are essential to facilitate genomics and its growing applications in health research and translational medicine in Africa. Using a cervical cancer cohort, this study describes the establishment of a biorepository consisting of biospecimens and matched phenotype …

Zimbabwe, us, Afrique du Sud (code pays fourni par la source)

Cervical cancer management in Zimbabwe (2019–2020)

Petmore Zibako, Nomsa Tsikai, Sarah Manyame, Themba G. Ginindza

BACKGROUND: Globally, cervical cancer is the fourth most commonly diagnosed cancer amongst women, and it is especially common in low- and middle-income countries (LMICs). The aim of the study was to determine the current patterns and characteristics of CC management in Zimbabwe …

Afrique du Sud, Zimbabwe (code pays fourni par la source)

Mapping Evidence on Management of Cervical Cancer in Sub-Saharan Africa: Scoping Review

Petmore Zibako, Mbuzeleni Hlongwa, Nomsa Tsikai, Sarah Manyame et autres

Cervical cancer (CC) is the most common viral infection of the reproductive tract and in Sub-Saharan Africa (SSA), its morbidity and mortality rates are high. The aim of this review was to map evidence on CC management in SSA. The scoping review …

Afrique du Sud, Zimbabwe (code pays fourni par la source)

Recurrent squamous cell carcinoma of the skin treated with immunotherapy

B J Srinivasa, P.S. Sridhar, Bhanu Prakash Lalkota, Nomsa Tsikai et autres

Squamous cell carcinoma (SCC) has a good prognosis, while metastatic tumors have aggressive behavior. Immunotherapy has become a standard line of treatment in metastatic cancers; pembrolizumab has shown promising results and improved quality of life in recurrent and metastatic cancers. We report …

in, Zimbabwe (code pays fourni par la source)

Knowledge, attitude and practice towards cervical cancer prevention among mothers of girls aged between 9 and 14 years: a cross sectional survey in Zimbabwe

Petmore Zibako, Nomsa Tsikai, Sarah Manyame, Themba G. Ginindza

BACKGROUND: Cervical cancer (CC) morbidity and mortality is still high in developing countries like Zimbabwe. Treatment for CC is out of reach for many women, hence the need to maximise on prevention which mainly includes screening and administering human papillomavirus (HPV) vaccine. …

Afrique du Sud, Zimbabwe (code pays fourni par la source)

Clinical and demographic characteristics of cervical cancer patients presenting at Parirenyatwa Hospital, Zimbabwe.

Oppah Kuguyo, Nomsa Tsikai, Senelisiwe Chipo Muradzikwa, Kudakwashe Mhandire et autres

Cervical cancer is the leading cause of cancer deaths in women in Africa, predominately due to late diagnosis. This study aims to identify risk factors, potential prognostic indicators, and optimal treatment modalities for Zimbabwean cervical cancer patients. Medical records for 1063 cervical …

Zimbabwe, Afrique du Sud (code pays fourni par la source)

Mapping evidence on management of cervical cancer in sub-Saharan Africa: scoping review protocol

Petmore Zibako, Mbuzeleni Hlongwa, Nomsa Tsikai, Sarah Manyame et autres

BACKGROUND: Cancer is a non-communicable disease and is the number 2 leading cause of death globally. Among all cancers, cervical cancer is the number 1 killer of women in low-income countries (LICs). Cervical cancer is a well understood preventable cancer. The rates …

Afrique du Sud, Zimbabwe (code pays fourni par la source)